Freneslerbart/Mevonlerbart
伏瑞莱拜单抗/美莱拜单抗
Report date: 2024/12/12 16:45:21
Base Information
Drug NameFreneslerbart/Mevonlerbart
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[5]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[10]
CombinationsYes
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesRegeneron Pharmaceuticals Inc
China Registration ClassN/A
Develop Information
Active CompaniesRegeneron Pharmaceuticals Inc
Inactive CompaniesN/A
Active Indications
Inactive Indications +[4]
Other Information
ATC CodeN/A
Related LinksN/A